oncology

Showing 15 posts of 328 posts found.

ASH 2014 meeting

Bayer and Novartis to debut new data at ASH 2015

November 30, 2015
Research and Development, Sales and Marketing American Society of Hematology, Bayer, Conference, Novartis, ash, clinical trials, haematology, oncology

Pharma firms will present clinical trial results for the pipeline drugs they are pinning their 2016 hopes for success on, …

Chest x ray

Lilly cancer drug gets US approval

November 26, 2015
NSCLC, Portrazza, lilly, lung cancer, necitumumab, non-small cell lung cancer, oncology

Eli Lilly has received FDA approval for its monoclonal antibody Portrazza, in combination with gemcitabine and cisplatin, for patients with …

Takeda oncology

Challenges in oncology R&D – part 2

November 25, 2015
Manufacturing and Production, Research and Development R&D, Takeda, oncology

Pharmafile put questions on the challenges pharma companies face when working in oncology R&D to Dixie-Lee Esseltine, vice president of …

Takeda oncology

Challenges in oncology R&D

November 18, 2015
Manufacturing and Production, Research and Development Dixie-Lee Esseltine, Takeda, Takeda oncology, Velcade, multiple myeloma, oncology

Pharmafile put questions on the challenges pharma companies face when working in oncology R&D to Dixie-Lee Esseltine, vice president of …

Merck R&D

Merck and Selvita form oncology partnership

November 2, 2015
Research and Development, Sales and Marketing Merck, Selvita, collaboration, oncology

Merck has entered a three-year agreement with Selvita to validate new therapeutic concepts in the field of oncology. The aim …

Counting the true cost of the Cancer Drugs Fund cuts

September 14, 2015
Research and Development Cancer, Cancer Drugs Fund, NHS, clinical trials, cuts, oncology

Leading figures from the pharma industry and cancer charities reacted with dismay to the recent cuts to the Cancer Drugs …

cells

How ‘deep reading’ of the scientific literature will benefit pharma

September 3, 2015
Research and Development Big Data, Cancer, Data Mining, R&D, literature search, oncology

The US Defense Advanced Research Projects Agency (DARPA)’s $45 million ‘Big Mechanism’ initiative has an ambitious aim.It promises to “leapfrog …

Logos

AstraZeneca and Peregrine in immuno-oncology collaboration

August 24, 2015
Research and Development AstraZeneca, Cancer, MEDI4736, Peregrine, Peregrine Pharmaceuticals, bavituximab, durvalumab, immunoncology, immunotherapy, oncology, tumours

AstraZeneca and Peregrine Pharmaceuticals will collaborate on a clinical trial to test two of the companies’ cancer treatments. The Phase …

Keytruda image

Merck in immuno-oncology collaboration with major cancer research centre

August 14, 2015
Research and Development Cancer, Merck, keytruda, oncology

Merck is teaming up with the University of Texas to evaluate Merck’s anti-PD-1 therapy, Keytruda, in combination with other treatmentsA team …

MedImmune building

MedImmune and Inovio collaborate on cancer vaccine

August 11, 2015
Manufacturing and Production, Research and Development AstraZeneca, HPV, Inovio, MedImmune, cancer vaccines, cervical cancer, oncology

MedImmune has entered into a license agreement and collaboration with Inovio, a biotechnology company developing DNA-based immunotherapies for cancer and …

Amgen image

Amgen bets on immunotherapy future

June 15, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, immunotherapy, oncology, oncolytic, tom lillie

When we speak to Tom Lillie he’s brimming with excitement about the future for Amgen in oncology and the future …

lilly_logo_building

Lilly and AstraZeneca collaborate on cancer trials

May 29, 2015
Research and Development AstraZeneca, Cancer, Eli Lilly, MedImmune, immuno-oncology, immunotherapy, lilly, oncology, phase I

AstraZeneca and Eli Lilly are teaming up to run a clinical trial of two of the companies’ anti-cancer drugs. The …

Industry awaits key immunotherapy results at ASCO

May 20, 2015
Research and Development, Sales and Marketing ASCO, Cancer, oncology, pharma

This year’s American Society of Clinical Oncology (ASCO) conference has a strong focus on immunotherapy, as pharma ramps up its …

Baxter buys cancer portfolio for $900 million

May 13, 2015
Research and Development, Sales and Marketing Cancer, Oncaspar, Sigma-Tau Finanziaria, baxter, oncology

Baxter is buying leukaemia treatment Oncaspar from Italian firm Sigma-Tau Finanziaria for $900 million as the US firm looks to …

Keytruda image

Worldwide cancer spending tops $100 billion

May 5, 2015
Research and Development, Sales and Marketing Cancer, IMS Health, keytruda, oncology

Over $100 billion was spent on cancer medicines across the world last year as a new generation of drugs begins …

The Gateway to Local Adoption Series

Latest content